Sukhvinder S. Johal
Health Economics & Payer Evidence Director, AstraZeneca
Sukhvinder S. Johal is listed as Health Economics & Payer Evidence Director, AstraZeneca. Sukhvinder spoke at ISPOR Europe 2026 in November 2026 (speaker, “Case Studies in Med Tech Evaluation”). Speaks mainly at Hospitals and Health Care events.
Compiled from published conference agendas; not yet confirmed by Sukhvinder. Is this you? Claim this profile.
- Sector: Hospitals and Health Care
Sessions at 1 conference
ISPOR Europe 2026 8 November 2026 – 11 November 2026
- Case Studies in Med Tech Evaluation Speaker · 9 November 2026
Spoke alongside
People who have shared a session with Sukhvinder at events on B2DB.
- Abeer A Al Rabayah King Hussein Cancer Center 1 shared session
- Claudia Roeder Director, Evidence and Value Development CM&E and Fertility · Merck Healthcare 1 shared session
- Fatima Wafqui Mohammed VI Center for Research and Innovation 1 shared session
- Lisa Masucci The Ottawa Hospital 1 shared session
Others from AstraZeneca
- Paul Hudson President, AstraZeneca US and Executive Vice President, North America 5 sessions
- Shaun Grady Chair of AstraZeneca UK 4 sessions
- Olga Obrezanova Principal Scientist, Augmented Biologics Design 3 sessions
- Christof Jaeger Senior Director - Data Science & Modelling - Substance, Pharmaceutical Sciences 2 sessions
- Goran Dahl Associate Principal Scientist 2 sessions
- Melanie Leveridge Vice President Assays, Profiling & Cell Sciences 2 sessions
- Miranda Cooper Statistical Science Director 2 sessions
- Roger Kirby Senior Enterprise Architect 2 sessions
- Semra Kitchen Senior Director, Search & Evaluation, R&I 2 sessions
- Stefan Geschwindner Director Biophysics 2 sessions
- Amberley Stephens Associate Principal Scientist 1 session
- Andre Verhoek HTA & Modelling Science Director 1 session